Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A ferritin prediction model to determine individual blood donation frequencies.

Transfusion·2026
Same author

Trust Over Knowledge: Rethinking Donor Iron Supplementation Strategies in Modern Blood Services-Authors' reply.

Transfusion medicine reviews·2026
Same author

Protection of fundamental human rights by improving patient access to plasma-derived therapies and donor health protection.

Vox sanguinis·2026
Same author

Impact of Ferritin-Guided Donation Interval Policies in the Netherlands and France.

Transfusion medicine reviews·2026
Same author

Knowledge Related to Blood Donation and Iron, and Willingness to Take Iron Supplements Among Blood Donors in Multiple Countries.

Transfusion medicine reviews·2026
Same author

Donation-Induced Protein and Iron Depletion in High-Frequency Plasma Donors.

Transfusion medicine reviews·2026
Same journal

Identifying blood deserts in Liberia: A geospatial analysis.

Transfusion·2026
Same journal

Clot contraction of whole blood diminishes during storage and can be restored by adding platelets.

Transfusion·2026
Same journal

Investigation of the preanalytical stability of blood donor samples.

Transfusion·2026
Same journal

The need for dried plasma-Still a national issue: Where are we and recommendations.

Transfusion·2026
Same journal

Spray dried plasma manufactured from apheresis and whole blood derived plasma.

Transfusion·2026
Same journal

Identification of a novel ABO*A1.01 allele with c.562C>T (p.Arg188Cys) mutation associated with A<sub>el</sub> phenotype in a Chinese individual.

Transfusion·2026
See all related articles

Related Experiment Video

Updated: Apr 10, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K

Minimum donation intervals should be reconsidered to decrease low hemoglobin deferral in whole blood donors: an

A Mireille Baart1, Katja van den Hurk1, Wim L A M de Kort1

  • 1Department of Donor Studies, Sanquin Research, Amsterdam, The Netherlands.

Transfusion
|June 16, 2015
PubMed
Summary
This summary is machine-generated.

Donor deferrals due to low hemoglobin (Hb) are common. This study found that shorter donation intervals and lower prior Hb levels increase deferral risk, suggesting personalized donation intervals could reduce deferrals.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.7K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K

Related Experiment Videos

Last Updated: Apr 10, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.7K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K

Area of Science:

  • Hematology
  • Blood Transfusion Medicine
  • Public Health

Background:

  • Low hemoglobin (Hb) levels are a primary cause of donor deferrals.
  • Previous Hb levels and donation intervals are linked to deferral but not previously quantified.

Purpose of the Study:

  • To quantify the relationship between Hb deferral prevalence and prior Hb levels and donation intervals.
  • To inform potential adjustments in blood donation protocols.

Main Methods:

  • Analyzed data from 220,946 whole blood donors.
  • Categorized donors by previous Hb levels and donation intervals.
  • Assessed Hb deferral prevalence within these categories.

Main Results:

  • Higher Hb deferral rates observed with lower previous Hb levels and shorter donation intervals.
  • A donation interval under 3 months required Hb levels at least 0.3 mmol/L above the cutoff to stay below 10% deferral.

Conclusions:

  • The standard 56-day minimum donation interval may be insufficient for many donors.
  • Revising donation intervals based on individual Hb history could decrease low Hb deferrals.
  • Personalized donation protocols may improve donor retention and blood supply.